Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis

Clinical trial NCT04643639 · COMPLETED

Trial details

NCT number: NCT04643639
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sepsis Immune Deficiency Hemoperfusion Blood Purification

Start date: 2020-09-16
Primary completion: 2022-10-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.